Impact of COVID-19 on Prequalification activities

On 30 January 2020, WHO Director-General, Dr Tedros Ghebreyesus declared that the outbreak of COVID-19 caused by the 2019 novel coronavirus (SARS-CoV-2) constitutes a Public Health Emergency of...

First meropenem prequalified

WHO Prequalification Unit (PQT) added the below new product to its prequalified list: TB384 - Meropenem - 1g - Powder for solution for injection - Venus Pharma GmbH - GERMANY Related Links...

First biosimilar product prequalified

WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list: BT-ON001 - Trastuzumab - 150mg - Powder for concentrate for solution for infusion - Samsung Bioepis...